Literature DB >> 13947810

Cholestatic hepatitis caused by esters of erythromycin and oleandomycin.

F I GILBERT.   

Abstract

Entities:  

Keywords:  DRUG ALLERGY; ERYTHROMYCIN; TRIACETYLOLEANDOMYCIN

Mesh：

Substances：

Year:  1962        PMID： 13947810     DOI： 10.1001/jama.1962.03050490072017d

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Cholestatic and hepatocellular injury associated with erythromycin esters: report of nine cases.

Authors:  E S Zafrani; K G Ishak; C Rudzki
Journal:  Dig Dis Sci       Date:  1979-05       Impact factor: 3.199

2.  Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate.

Authors:  E B Keeffe; T C Reis; J E Berland
Journal:  Dig Dis Sci       Date:  1982-08       Impact factor: 3.199

Review 3.  Adverse effects of macrolide antibacterials.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

4.  Gastrointestinal motor-stimulating activity of macrolide antibiotics and analysis of their side effects on the canine gut.

Authors:  Z Itoh; T Suzuki; M Nakaya; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

Review 5.  Macrolides: From Toxins to Therapeutics.

Authors:  Kiersten D Lenz; Katja E Klosterman; Harshini Mukundan; Jessica Z Kubicek-Sutherland
Journal:  Toxins (Basel)       Date:  2021-05-12       Impact factor: 4.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.